Hakan Goker

NPI: 1568184588
Total Payments
$500.03
2024 Payments
$298.20
Companies
5
Transactions
9

Payment Breakdown by Category

Food & Beverage$491.58 (98.3%)
Education$8.45 (1.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $491.58 8 98.3%
Education $8.45 1 1.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $287.27 4 $0 (2024)
Daiichi Sankyo Inc. $117.80 1 $0 (2024)
Janssen Biotech, Inc. $45.54 2 $0 (2023)
Astellas Pharma US Inc $28.06 1 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $21.36 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $298.20 4 ABBVIE INC. ($152.34)
2023 $201.83 5 ABBVIE INC. ($134.93)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/07/2024 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $28.06 General
Category: Oncology
02/23/2024 ABBVIE INC. EPKINLY (Drug) Food and Beverage In-kind items and services $32.85 General
Category: ONCOLOGY
01/25/2024 Daiichi Sankyo Inc. Vanflyta (Drug) Food and Beverage In-kind items and services $117.80 General
Category: ONCOLOGY
01/24/2024 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $119.49 General
Category: ONCOLOGY
11/29/2023 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $21.36 General
Category: ONCOLOGY
10/26/2023 ABBVIE INC. VENCLEXTA (Drug) Food and Beverage In-kind items and services $126.48 General
Category: ONCOLOGY
10/26/2023 ABBVIE INC. VENCLEXTA (Drug) Education In-kind items and services $8.45 General
Category: ONCOLOGY
10/02/2023 Janssen Biotech, Inc. TECVAYLI (Biological), DARZALEX, IMBRUVICA Food and Beverage In-kind items and services $23.17 General
Category: Oncology
08/08/2023 Janssen Biotech, Inc. DARZALEX (Biological), IMBRUVICA, TECVAYLI Food and Beverage In-kind items and services $22.37 General
Category: Oncology

About Hakan Goker

Hakan Goker is a Hematology & Oncology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2022. The National Provider Identifier (NPI) number assigned to this provider is 1568184588.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hakan Goker has received a total of $500.03 in payments from pharmaceutical and medical device companies, with $298.20 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($491.58).

Practice Information

  • Specialty Hematology & Oncology
  • Other Specialties Hematology & Oncology, Hematology & Oncology
  • Location Kansas City, MO
  • Active Since 09/15/2022
  • Last Updated 08/07/2023
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1568184588

Products in Payments

  • VENCLEXTA (Drug) $254.42
  • Vanflyta (Drug) $117.80
  • EPKINLY (Drug) $32.85
  • Padcev (Drug) $28.06
  • TECVAYLI (Biological) $23.17
  • DARZALEX (Biological) $22.37
  • IMBRUVICA (Drug) $21.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Kansas City